BR0215081A - Proteìnas purificadas do envoltório do vìrus de hepatite c para uso diagnóstico e terapêutico - Google Patents
Proteìnas purificadas do envoltório do vìrus de hepatite c para uso diagnóstico e terapêuticoInfo
- Publication number
- BR0215081A BR0215081A BR0215081-6A BR0215081A BR0215081A BR 0215081 A BR0215081 A BR 0215081A BR 0215081 A BR0215081 A BR 0215081A BR 0215081 A BR0215081 A BR 0215081A
- Authority
- BR
- Brazil
- Prior art keywords
- relates
- proteins
- wrap
- diagnostic
- present
- Prior art date
Links
- 108090000623 proteins and genes Proteins 0.000 title abstract 4
- 102000004169 proteins and genes Human genes 0.000 title abstract 4
- 230000001225 therapeutic effect Effects 0.000 title abstract 3
- 241000711549 Hepacivirus C Species 0.000 title 1
- BWGNESOTFCXPMA-UHFFFAOYSA-N Dihydrogen disulfide Chemical compound SS BWGNESOTFCXPMA-UHFFFAOYSA-N 0.000 abstract 2
- 238000003776 cleavage reaction Methods 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 239000000203 mixture Substances 0.000 abstract 2
- 230000007017 scission Effects 0.000 abstract 2
- 108700008783 Hepatitis C virus E1 Proteins 0.000 abstract 1
- 241000700605 Viruses Species 0.000 abstract 1
- 230000009089 cytolysis Effects 0.000 abstract 1
- 238000003745 diagnosis Methods 0.000 abstract 1
- 238000012544 monitoring process Methods 0.000 abstract 1
- 102000004196 processed proteins & peptides Human genes 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 238000004393 prognosis Methods 0.000 abstract 1
- 238000000746 purification Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/29—Hepatitis virus
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
- C07K14/08—RNA viruses
- C07K14/18—Togaviridae; Flaviviridae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/24011—Flaviviridae
- C12N2770/24211—Hepacivirus, e.g. hepatitis C virus, hepatitis G virus
- C12N2770/24222—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Gastroenterology & Hepatology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Oncology (AREA)
- Biophysics (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US2051001A | 2001-12-18 | 2001-12-18 | |
| US41835802P | 2002-10-16 | 2002-10-16 | |
| PCT/EP2002/014480 WO2003051912A2 (fr) | 2001-12-18 | 2002-12-18 | Proteines purifiees du virus de l'hepatite c utilisables en diagnostic et therapie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BR0215081A true BR0215081A (pt) | 2004-10-19 |
Family
ID=26693530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BR0215081-6A BR0215081A (pt) | 2001-12-18 | 2002-12-18 | Proteìnas purificadas do envoltório do vìrus de hepatite c para uso diagnóstico e terapêutico |
Country Status (12)
| Country | Link |
|---|---|
| EP (1) | EP1461080A2 (fr) |
| JP (1) | JP2005516939A (fr) |
| KR (1) | KR20040076869A (fr) |
| CN (1) | CN1622828A (fr) |
| AU (1) | AU2002361160B2 (fr) |
| BR (1) | BR0215081A (fr) |
| CA (1) | CA2468690A1 (fr) |
| IL (1) | IL162236A0 (fr) |
| MX (1) | MXPA04005891A (fr) |
| NZ (1) | NZ533396A (fr) |
| RU (1) | RU2319505C2 (fr) |
| WO (1) | WO2003051912A2 (fr) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7108855B2 (en) | 1998-06-24 | 2006-09-19 | Innogenetics N.V. | Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| US7101561B2 (en) | 2000-12-01 | 2006-09-05 | Innogenetics N.V. | Purified hepatitis C virus envelope proteins for diagnostic and therapeutic use |
| WO2002085932A2 (fr) | 2001-04-24 | 2002-10-31 | Innogenetics N.V. | Constructions et methodes relatives a l'expression de proteines d'enveloppe recombinantes du vhc |
| FR2859221B1 (fr) * | 2003-08-28 | 2005-10-14 | Centre Nat Rech Scient | Vecteur de co-expression de domaines membranaires de proteines d'enveloppe d'un virus et utilisations |
| EP1574517A1 (fr) | 2004-03-09 | 2005-09-14 | Innogenetics N.V. | HCV E1 contenant les ponts disulfure spécifiques |
| EP1809773B1 (fr) * | 2004-10-18 | 2014-07-16 | Globeimmune, Inc. | Moyens therapeutiques a base de levure contre l'infection par hepatite c chronique |
| CN100365124C (zh) * | 2005-10-27 | 2008-01-30 | 云南大学 | 一段丙型肝炎病毒特异性cDNA序列的应用 |
| WO2009030872A1 (fr) * | 2007-09-07 | 2009-03-12 | Mats Axel Atterdag Persson | Matériaux et procédés pour le traitement de l'hépatite c |
| SI2285408T1 (sl) | 2008-06-05 | 2019-02-28 | Ablynx N.V. | Aminokislinska zaporedja usmerjena proti proteinom ovojnicam virusa in polipeptidi, ki zaporedja vsebujejo za zdravljenje virusnih bolezni |
| NZ597314A (en) | 2009-06-05 | 2013-07-26 | Ablynx Nv | Monovalent, bivalent and trivalent anti human respiratory syncytial virus (hrsv) nanobody constructs for the prevention and/or treatment of respiratory tract infections |
| EP2507262A1 (fr) | 2009-11-30 | 2012-10-10 | Ablynx N.V. | Séquences d'acides aminés améliorées dirigées contre le virus syncytial respiratoire humain (hrsv) et polypeptides comprenant celles-ci pour la prévention et/ou le traitement d'infections du tractus respiratoire |
| EP2720716B1 (fr) | 2011-06-14 | 2018-03-21 | Globeimmune, Inc. | Compositions immunotherapeutiques pour le traitement ou prévention d'une infection par le virus delta de l'hépatite |
| RU2570553C2 (ru) * | 2013-11-20 | 2015-12-10 | Федеральное бюджетное учреждение "Всероссийский научно-исследовательский институт лесоводства и механизации лесного хозяйства (ФБУ ВНИИЛМ) | Способ очистки вирусных полиэдров |
| CN104327170A (zh) * | 2014-05-16 | 2015-02-04 | 中国疾病预防控制中心病毒病预防控制所 | 丙型肝炎病毒(hcv)细胞进入抑制肽zte1序列及应用 |
| CN107002079A (zh) | 2014-09-17 | 2017-08-01 | 衣阿华大学研究基金会 | 作为免疫调节剂和疫苗组分的病毒rna区段 |
| US20190284230A1 (en) * | 2016-09-29 | 2019-09-19 | Macfarlane Burnet Institute For Medical Research And Public Health Limited | Assembled glycoproteins |
| WO2020117760A1 (fr) * | 2018-12-03 | 2020-06-11 | Duke University | Procédé de purification de nanoparticules et de protéines recombinantes |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK0992580T3 (da) * | 1993-11-04 | 2005-07-11 | Innogenetics Nv | Epitoper på human T-celler, som er immundominante for hepatitis C-virus |
| NZ508797A (en) * | 1998-06-24 | 2004-02-27 | Innogenetics N | Particles of HCV envelope proteins: use for vaccination |
-
2002
- 2002-12-18 RU RU2004116914/15A patent/RU2319505C2/ru not_active IP Right Cessation
- 2002-12-18 KR KR10-2004-7009720A patent/KR20040076869A/ko not_active Application Discontinuation
- 2002-12-18 CN CNA028282027A patent/CN1622828A/zh active Pending
- 2002-12-18 EP EP02796675A patent/EP1461080A2/fr not_active Withdrawn
- 2002-12-18 WO PCT/EP2002/014480 patent/WO2003051912A2/fr active IP Right Grant
- 2002-12-18 CA CA002468690A patent/CA2468690A1/fr not_active Abandoned
- 2002-12-18 AU AU2002361160A patent/AU2002361160B2/en not_active Expired - Fee Related
- 2002-12-18 NZ NZ533396A patent/NZ533396A/en unknown
- 2002-12-18 JP JP2003552792A patent/JP2005516939A/ja active Pending
- 2002-12-18 BR BR0215081-6A patent/BR0215081A/pt not_active IP Right Cessation
- 2002-12-18 IL IL16223602A patent/IL162236A0/xx unknown
-
2004
- 2004-06-16 MX MXPA04005891A patent/MXPA04005891A/es not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| CN1622828A (zh) | 2005-06-01 |
| KR20040076869A (ko) | 2004-09-03 |
| NZ533396A (en) | 2005-04-29 |
| AU2002361160B2 (en) | 2008-07-03 |
| EP1461080A2 (fr) | 2004-09-29 |
| RU2319505C2 (ru) | 2008-03-20 |
| WO2003051912A9 (fr) | 2004-07-15 |
| WO2003051912A3 (fr) | 2004-03-04 |
| JP2005516939A (ja) | 2005-06-09 |
| CA2468690A1 (fr) | 2003-06-26 |
| MXPA04005891A (es) | 2004-09-13 |
| AU2002361160A1 (en) | 2003-06-30 |
| WO2003051912A2 (fr) | 2003-06-26 |
| IL162236A0 (en) | 2005-11-20 |
| RU2004116914A (ru) | 2005-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BR0215081A (pt) | Proteìnas purificadas do envoltório do vìrus de hepatite c para uso diagnóstico e terapêutico | |
| WO1996004385A3 (fr) | Proteines purifiees d'enveloppe de virus de l'hepatite c a usage diagnostic et therapeutique | |
| Starcher et al. | Purification and comparison of elastins from different animal species | |
| AU744184B2 (en) | Peptide with radio protective effect | |
| BR0109494A (pt) | Produção de fatores recombinantes de coagulação do sangue em linhas celulares humanas | |
| EP1484339A3 (fr) | Protéines de "Domaine de Kunitz" a actvité antikallikreine et acides nucléiques les codant | |
| BR9712518A (pt) | Polipeptìdeo, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processo para detectar tuberculose em um paciente, e, kit diagnóstico | |
| BR0116370A (pt) | Composto, composição farmacêutica, uso de um composto, e, método de tratamento de uma doença ou condição mediada por hppar em um paciente. | |
| BR0210391A (pt) | Composto, métodos de tratar um paciente que tenha ou de prevenir um paciente de contrair uma doença ou condição e de preparar um composto, e, uso de um composto | |
| DE69637914D1 (de) | Impstoff gegen den für atemwegs- und reproduktionserkrankungen beim schwein verantwortlichen virus | |
| DE69940439D1 (de) | Streptococcus pneumoniae proteine und immunogene fragmente für impstoffe | |
| DE69922958D1 (de) | Hcv hüllproteine partikel : verwendung für therapeutische impfung | |
| BRPI0409624A (pt) | 2-hidróxi-3-diaminoalcanos de benzamida | |
| WO2000077216A3 (fr) | Vaccin poxvirus recombine contre le circovirus porcin | |
| IL164643A (en) | Peptides, immunogenic compositions containing them and use thereof for the preparation of medicaments for the treatment of alzheimer's disease | |
| BR9809445A (pt) | Polipeptìdeo compreendendo uma porção imunogênica de um antìgeno de m. tubercolosis, molécula de dna, vetor de expressão, célula hospedeira, composição farmacêutica, vacina, proteìna de fusão, processos para indução de imunidade protetora em um paciente, processo de detecção de tuberculose em um paciente,e , kit de diagnóstico. | |
| DE69532996D1 (de) | Peptidanaloge des menschlichen basischen myelinproteins | |
| AU6020099A (en) | Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein | |
| BR0214188A (pt) | Anticorpos monoclonais contra vìrus da hepatite e ou seus fragmentos com atividade de ligação e uso dos mesmos | |
| Rose et al. | Proteolytic fragmentation and peptide mapping of human carboxyamidomethylated tracheobronchial mucin | |
| BR0309570A (pt) | Fatores camp quiméricos para vacinação contra infecção por streptococcus | |
| BR9607628A (pt) | Mólecula proteinácea biologicamente isolada, molécula recombinante, fragmento de peptìdeo, molécula de ácido nucleico, composição farmacêutica, e, processos para preparar uma molécula recombinante e para induzir a proliferação astroglial em um mamìfero | |
| Wu et al. | Conformation of naturally-occurring peptides in surfactant solution: its relation to the structure-forming potential of amino acid sequence | |
| BR0203518A (pt) | Proteìnas purificadas do envelope do vìrus de hepatite c para uso diagnóstico e terapêutico | |
| BR0206995A (pt) | Tratamento do vìrus da hepatite b |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A(S) 7A E 8A ANUIDADE(S). |
|
| B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2108 DE 31/05/2011. |